Health Canada recalls Life Brand Melatonin, Riva Acetaminophen for dosage concerns
Advertisement
Read this article for free:
or
Already have an account? Log in here »
We need your support!
Local journalism needs your support!
As we navigate through unprecedented times, our journalists are working harder than ever to bring you the latest local updates to keep you safe and informed.
Now, more than ever, we need your support.
Starting at $15.99 plus taxes every four weeks you can access your Brandon Sun online and full access to all content as it appears on our website.
Subscribe Nowor call circulation directly at (204) 727-0527.
Your pledge helps to ensure we provide the news that matters most to your community!
To continue reading, please subscribe:
Add Brandon Sun access to your Free Press subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $20.00 plus GST for four weeks. After four weeks, your payment will increase to $24.00 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 18/04/2025 (281 days ago), so information in it may no longer be current.
Canada’s federal health authority has issued a recall warning for two medications over incorrect dosing concerns.
Health Canada issued a recall for Life Brand Timed Release Melatonin 10mg on Tuesday, warning in a news release the product is labelled with incorrect dosing instruction.
The affected lot numbers are 4D3965YA2, 4F4495YA2, 4F44961B0, 4F44962LH, 4H49262LH and 5C47764ES.
The health authority issued a separate news release for Riva Acetaminophen 500mg with the lot number D3120 on the same day, saying the affected lot might contain tablets with 325 milligrams of the drug.
Health Canada says in both releases the recalled products were distributed nationally.
It says consumers should contact their health-care providers before they stop using of any the affected products or for any health concerns, and to report any side-effects related to taking recalled medications.
This report by The Canadian Press was first published April 18, 2025.